Author: Ken Dropiewski

AngioInsight, Inc. Announces the SMARTFLOW Pivotal Clinical Study

AI-Powered AngioAI+™ Platform to Enhance Cardiovascular Disease Diagnosis, Including Coronary Microvascular Disease (CMD) MINNETONKA, Minn.–(BUSINESS WIRE)–AngioInsight, Inc., a leader in AI-driven cardiovascular solutions, today announced the upcoming launch of its pivotal clinical study, SMARTFLOW ™, to evaluate the diagnostic accuracy and effectiveness of its innovative AngioAI+ platform. Designed to revolutionize angiography imaging […]

Elixir Medical Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025

Developer of disruptive technologies to treat cardiovascular and peripheral disease joins the ranks of Waymo, Nvidia, Duolingo, and more MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping […]

First-in-Human Clinical Results for SonoVascular’s SonoThrombectomy™ System Presented at the 2025 Annual Meeting of the American Venous Forum

CHAPEL HILL, N.C., March 18, 2025 /PRNewswire/ — SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomy™ System for venous thromboembolism (VTE), a novel treatment solution intended to provide better outcomes for millions of…

Remedy Pharmaceuticals Secures Key U.S. Patent Allowance for CIRARA® in Treating Large Hemispheric Infarction, Including Wake-Up Strokes

NEW YORK, March 18, 2025 /PRNewswire/ — Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric infarction (LHI) drug, CIRARA (IV glyburide). The…